好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Biological Effects of a Potent, Muscle-Targeted, Orally Bioavailable Calpain Inhibitor (C101) for Duchenne Muscular Dystrophy (DMD)
Muscle Disease/Neuromuscular Junction
(-)
002
Authors/Disclosures
Norman W. Barton, MD, PhD Dr. Barton has received personal compensation for serving as an employee of Takeda Pharmaceutical Co. LTD. Dr. Barton has received stock or an ownership interest from Takeda Pharmaceutical Co. LTD.
Sadiqa Mahmood, BDS (Partners Healthcare) No disclosure on file
No disclosure on file
Syed F. Ali, MD (University of Arkansas Medical Sciences) No disclosure on file
No disclosure on file
Khawja A. Siddiqui, MD (Baylor St Lukes Medical Center) Dr. Siddiqui has nothing to disclose.
No disclosure on file
Saroja A.O. Saroja A.O. has nothing to disclose.
Abigail Cohen No disclosure on file
Theresa Michele, MD No disclosure on file
Lee H. Schwamm, MD, FAAN (Yale New Haven Health System) Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime 好色先生. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file